Product search
Filter
Search results
FVIII Inhibitor Plasma (2) Moderate (11-50 BU/ml), frozen
Can be used as a substitute for plasmas from patients that have developed neutralizing antibodies to coagulation factors. For research use only.
FVII Inhibitor Plasma (2) Moderate (11-50 BU/ml), frozen
Can be used as a substitute for plasmas from patients that have developed neutralizing antibodies to coagulation factors. For research use only.
ZYMUTEST Tissue Factor Total
Assay proposed for the measurement of total tissue factor in research application.
LIAPHEN Fibrinogen
Assay of fibrinogen in human citrated plasma or in cell culture supernatants.
FVIII Inhibitor Plasma (3) strong (51-200 BU/ml), lyophilized
Can be used as a substitute for plasmas from patients that have developed neutralizing antibodies to coagulation factors. For research use only.
FVII Inhibitor Plasma (3) strong (51-200 BU/ml), frozen
Can be used as a substitute for plasmas from patients that have developed neutralizing antibodies to coagulation factors. For research use only.
HEMOCLOT DTI 1 (Direct Thrombin Inhibitors)
Quantitative measurement of dabigatran, and anti-thrombin activities in plasma.
HEMOCLOT Protein S
Diagnosis of congenital or acquired protein S deficiencies, associated with an increase risk of thrombosis.
HEMOCLOT Protein C
Diagnosis of congenital or acquired protein C deficiencies. Protein C concentrates.
Ristocetin
The ristocetin reagent is proposed for platelet aggregation tests, as an aid for the detection of von Willebrand disease, von Willebrand factor (vWF) determination, and identification of Bernard-Soulier syndrome.